Published in Cancer Weekly, December 6th, 2005
The research published in Cancer Research is the first to show that patients with high levels of the protein BCA2 are less likely to experience breast cancer re-occurrence than patients with low levels of BCA2.
"For the first time we have been able to show that the over-expression of BCA2 is a favorable factor in breast cancer in relation to occurrence of lymph node metastases and regional recurrence," says principle investigator Dr. Arun Seth, senior scientist in molecular and cellular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-12-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.